Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences
Go back to Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences| Labranche & Co (NASDAQ: LAB) | Delayed: 0.65 +0.01 (1.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.64 | 52 Week High | $4.47 | |||
| Open | $0.63 | 52 Week Low | $3.02 | |||
| Day High | $0.67 | P/E | N/A | |||
| Day Low | $0.63 | EPS | $-1.56 | |||
| Volume | 399,597 | |||||



